Low-dose tumor necrosis factor-alpha augments antitumor activity of stealth liposomal doxorubicin (DOXIL) in soft tissue sarcoma-bearing rats.

Source:http://linkedlifedata.com/resource/pubmed/id/10956394

Int. J. Cancer 2000 Sep 15 87 6 829-37

Download in:

View as

General Info

PMID
10956394